Semiparametric regression on cumulative incidence function with interval-censored competing risks data by Bakoyannis, Giorgos et al.
Semiparametric regression on cumulative incidence function 
with interval-censored competing risks data
Giorgos Bakoyannisa,*, Menggang Yub, and Constantin T. Yiannoutsosa
aDepartment of Biostatistics, Fairbanks School of Public Health and School of Medicine, Indiana 
University, Indianapolis, IN, USA
bDepartment of Biostatistics & Medical Informatics, University of Wisconsin-Madison, WI, USA
Abstract
Many biomedical and clinical studies with time-to-event outcomes involve competing risks data. 
These data are frequently subject to interval censoring. This means that the failure time is not 
precisely observed, but is only known to lie between two observation times such as clinical visits 
in a cohort study. Not taking into account the interval censoring may result in biased estimation of 
the cause-specific cumulative incidence function, an important quantity in the competing risk 
framework, used for evaluating interventions in populations, for studying the prognosis of various 
diseases and for prediction and implementation science purposes. In this work we consider the 
class of semiparametric generalized odds-rate transformation models in the context of sieve 
maximum likelihood estimation based on B-splines. This large class of models includes both the 
proportional odds and the proportional subdistribution hazard models (i.e., the Fine-Gray model) 
as special cases. The estimator for the regression parameter is shown to be semiparametrically 
efficient and asymptotically normal. Simulation studies suggest that the method performs well 
even with small sample sizes. As an illustration we use the proposed method to analyze data from 
HIV-infected individuals obtained from a large cohort study in sub-Saharan Africa. We also 
provide the R function ciregic that implements the proposed method and present an illustrative 
example.
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1. Introduction
Many biomedical studies with time-to-event outcomes involve competing risk data. The 
basic identifiable quantities from such data, are the cause-specific hazard and the cause-
specific cumulative incidence function. The latter quantity plays a key role in the evaluation 
of interventions on populations, in studying the prognosis of various diseases, and in 
prediction. Prediction in turn, is especially useful in quality of life studies and for general 
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implementation science purposes. Frequently, competing risks data are subject to interval 
censoring, that is, the times to the occurrence of an event are only known to lie between two 
observation times. An important example of interval-censored competing risk data, and the 
motivation for the present paper, comes from studies in HIV care and treatment programs. 
Individuals living with HIV who receive care in these programs may die while in care or 
become lost to care. Patients not retained in care are less likely to receive antiviral treatment 
(ART) and, frequently, any other clinical services. They are thus more likely to experience 
adverse clinical outcomes including death and viral rebound. The resulting increased 
infectivity of these patients may in addition significantly contribute to further expansion of 
the HIV epidemic in their communities. Identifying factors associated with mortality while 
in care and loss to care is useful for optimizing interventions, especially in sub-Saharan 
Africa, the region most affected by the HIV epidemic and the locus of the present study.
In many cases in this context, when a death has occurred, the corresponding death date is 
known to be between the date the death was reported and the last clinic visit of the deceased 
patient. Also, since loss to care is defined as no clinic visits for a certain period (e.g., three 
months from the last observed clinic visit or for the maximum period that a patient may have 
adequate medication supplies), the actual date of disengagement from care (being alive but 
not receiving anti-HIV care) is unknown. Consequently, studies in this context involve 
interval-censored competing risk data where death and loss to care are competing events. 
This research was motivated from studies in this setting and the fact that the issue of interval 
censoring in this context has, to our knowledge, been largely ignored in the literature.
Both nonparametric and fully parametric approaches have been proposed to estimate the 
cause-specific cumulative incidence function with interval-censored competing risk data. For 
example, Hudgens et al. [1] proposed a nonparametric maximum likelihood estimator for the 
cause-specific cumulative incidence under interval censoring. More recently, a parametric 
estimation method for the cause-specific cumulative incidence under a Gompertz 
distribution assumption was developed by Hudgens et al. [2]. These methods however do not 
consider covariates. To incorporate covariate information into a regression setting, fully 
parametric likelihood methods for the cause-specific cumulative incidence can be modified 
to deal with interval-censored competing risk data. For example, Jeong and Fine [3] 
proposed a parametric maximum likelihood approach along with a generalized odds-rate 
transformation [4] to model the cause-specific cumulative incidence under the Gompertz 
distribution. On the other hand, Cheng [5] proposed a three-parameter modified logistic 
model, while Shi et al. [6] considered a parametric method for explicitly modeling the 
cause-specific cumulative incidence of the cause of interest based on the generalized odds-
rate transformation [4] and the modified three-parameter logistic function proposed by 
Cheng [5].
A key limitation of the fully parametric methods is that they make strong distributional 
assumptions about the true cause-specific cumulative incidence functions. Additionally, 
using more flexible three-parameter distributions may be challenging computationally and 
may lead to non-convergence problems as in univariate survival analysis, as cautioned by 
Lambert et al. [7] for example. A general approach to overcome the limitations of the fully 
parametric methods is to consider a semiparametric model. This approach was used 
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successfully by Zhang et al. [8] for the Cox model with interval-censored (univariate) 
survival data. The authors used a sieve maximum likelihood estimation methodology [9] 
along with monotone B-splines to approximate the baseline hazard of the Cox proportional 
hazards model. Recently, Li [10] used the estimation approach by Zhang et al. [8] to the 
problem of semiparametric regression of the cumulative incidence function with interval-
censored competing risk data under the proportional subdistribution hazards or the Fine-
Gray model [11]. However, the assumption of proportional subdistribution hazards may not 
be correct and also the resulting parameter estimates are somewhat difficult to interpret as 
reported by Fine [12]. As we show in the illustration of our proposed methodology, using a 
proportional subdistribution hazard model for both competing risks did not provide a good 
fit to the data in our motivating HIV study compared to other models which better fit these 
data. Consequently, considering a more general class of semiparametric models for the 
cumulative incidence function, which also includes models which are easily interpretable by 
practitioners, such as, for example, the proportional odds model [12, 13], has important 
practical implications.
The main goal of this paper is to extend the B-spline sieve maximum likelihood estimator 
for interval-censored data used by [8] and [10], to the class of semiparametric generalized 
odds rate transformation models for the cause-specific cumulative incidence function and 
evaluate its asymptotic and finite sample properties. The large class of the generalized odds 
rate transformation models includes both the proportional odds model and the proportional 
subdistribution hazards model (i.e., the Fine-Gray model) [11] as special cases. Additionally, 
we explicitly incorporate the boundedness constraint of the cumulative incidence functions 
during the likelihood maximization. This is not the case with many existing methods for 
right-censored competing risk data that analyze each cause of failure separately and which 
can produce cumulative incidence estimates having a sum, over all possible causes of failure, 
which is greater than 1. For example, in the illustration presented by Choi and Huang [14], 
the analysis based on the Fine-Gray model [11] produced cumulative incidence estimates 
that added to 1.29. This may indicate a model misspecification and may adversely influence 
the validity of any predictions based on these estimates. The boundedness constraint was not 
considered by Li [10]. Finally, we develop and illustrate the R function ciregicthat easily 
implements the proposed estimation methodology for general interval-censored competing 
risks data.
We show that the B-spline sieve maximum likelihood estimator for the regression 
(Euclidean) parameter is shown to be semiparametrically efficient and asymptotically 
normal. We also demonstrate that the estimator for the functional parameter (baseline cause-
specific cumulative incidence functions) converges at the optimal rate for nonparametric 
regression, which is nevertheless slower than the usual parametric  rate. Simulation 
studies suggest that the method performs well even with small sample sizes. We illustrate 
our methods by considering a number of candidate models like the proportional 
subdistribution and proportional odds model in the analysis of death and loss to care in the 
context of data from HIV care and treatment programs. Finally, we conclude this manuscript 
with a discussion, while examples on how to use the R function ciregiccreated to fit these 
models and asymptotic theory proofs are reserved for the Appendix.
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2. Data and method
We assume the existence of a finite number k of competing risks. The cause of failure is 
denoted by C, the actual failure time is denoted by T, whereas (U1, …, Um) denote the m ∈ 
(0, ∞) distinct observation times. Observation times could be clinical visits, laboratory tests 
and all other occasions where the sampling unit (e.g., a patient) is actually observed. The 
number of observation times m may differ from subject to subject. To facilitate our further 
discussion let V ∈ {0, U1, …, Um} correspond to the last observation time prior to the 
failure and U ∈ {U1, …, Um, ∞} the first observation time after the failure. Using this 
notation a left-censored observation will correspond to (V, U) = (0, U1), while a right-
censored observation to (V, U) = (Um, ∞). For j = 1, …, k, if a subject fails from the j-th 
cause of failure before the first observation time U1 (i.e. it is left-censored), we observe 
. If he/she fails between V > U1 and U ≤ Um, we observe δj = 1. But if he/she is right-
censored (i.e. T > Um), then we observe . We assume the observation 
interval to be [a, b], that is a = U1 < Um = b. Along with the C, V, U,  and , 
we also observe a vector of covariates Z ∈ ℝd, whose effects are the primary parameters of 
interest. We further assume the following two fundamental conditions:
A1 The observation times (U1, …, Um) are independent of (T, C) conditional on Z.
A2 The distribution of (U1, …, Um) does not contain the parameters that govern the 
distribution of (T, C) (non-informative interval censoring).
The cause-specific cumulative incidence function is defined as
and corresponds to the cumulative probability of failure from the j-th cause of failure in the 
presence of the remaining causes of failure, conditional on the covariates. Given the two 
assumptions above, the likelihood function in terms of the cause-specific cumulative 
incidence functions is
(1)
where  is a parameter that includes, in our case, regression coefficients for 
the effect of the covariate vector Z on each cause-specific cumulative incidence function and 
unspecified functions of time. A natural choice for the model for Fj is the class of 
semiparametric transformation models [11, 3, 15]:
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(2)
where gj is a known increasing cause-specific link function and ϕj is an unspecified, strictly 
increasing and invertible function of time. A special subset of the class of semiparametric 
transformation models is the class of the generalized odds rate transformation models [4, 16, 
12, 3]:
for j = 1, …, k. The proportional odds model and the proportional subdistribution hazards 
model [11] are special cases of the generalized odds rate transformation with αj = 1 and αj = 
0, respectively [3]. Note that the link functions for different causes of failure are allowed to 
be different. All authors considering general classes of models assume that the true link 
functions are known [16, 17, 12, 18] and we adopt this assumption in our present work as 
well. This is because estimating α is not always possible because not all models with 
unknown α are identifiable from the data as in the non-competing-risk setting [19]. Even 
when there is no non-identifiability issues, reliable estimation of α requires very large 
sample sizes [19, 18].
As in [8] and [10], we avoid imposing parametric assumptions on ϕj in (2) and thus the 
likelihood involves k infinite-dimensional or functional parameters. In general, 
maximization of the likelihood function with an infinite-dimensional parameter θ ∈ Θ over 
Θ may lead to inconsistent maximum likelihood estimates [9]. One approach to overcome 
this problem is to use sieve maximum likelihood estimation. A sieve [9] is a sequence 
{Θn}n≥1 of parameter spaces that approximate in a certain sense the original parameter space 
Θ, with the approximation error tending to zero as n → ∞. A sieve maximum likelihood 
estimate is the estimate obtained by maximizing the likelihood function over Θn. Another 
practical advantage of using the sieve maximum likelihood approach is that it reduces the 
dimensionality of the optimization problem, and, thus, the computational burden, compared 
to a fully semiparametric likelihood approach [8]. This is because the dimension of Θn is 
significantly smaller (i.e., it involves fewer number of parameters to be estimated) compared 
to that of the full parameter space Θ in finite samples. The computational advantage of the 
sieve maximum likelihood approach compared to a fully semiparametric maximum 
likelihood approach for interval-censored survival data has been shown in the simulation 
study by Zhang et al. [8]. In our case, the sequence of approximating functional parameter 
spaces is chosen to be spaces of monotone (due to the monotonicity of the cumulative 
incidence function) B-spline functions as defined in [8], i.e.,
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for j = 1, …, k, where Nj and mj are the number of internal knots and the order of the B-
spline for the j-th cause of failure, γj are the unknown control points and t ∈[a, b], with a 
and b being the minimum and maximum observation times in the study. The number of 
internal knots Nj increases with sample size and is selected to satisfy Nj ≈ nν such that 
max1≤t≤Nj+1 (ct, j − ct−1, j) = O(n−ν), where ct, j is the place of the t-th knot for the j-th cause-
specific cumulative incidence function. During the likelihood maximization we impose the 
monotonicity constraints
for every s = 1, …, Nj + pj and j = 1, …, k. Additionally, the constraint max
(3)
is needed to ensure that the sum of the estimated cumulative incidence functions at the 
maximum follow-up time b is bounded above by 1, where the maximum is over all the 
observed covariate patterns.
Let the true parameter values be denoted by , where  and ϕ0 
= (ϕ1,0, …, ϕk,0)′ and the corresponding estimator by , where 
 and ϕ̂n = (ϕ̂1,n, …, ϕk̂,n)′. Also, define the L2-metric for the distance 
between two parameters θ1 = (β(1)′, ϕ(1)′)′ and θ2 = (β(2)′, ϕ(2)′)′ as
where
and ||·|| denotes the Euclidean norm. Here we assume that each unspecified function ϕ0, j(t), j 
= 1, …, k, is smooth in the sense that it has a bounded p-th derivative in [a, b] for p ≥ 1 and 
that the first derivative of ϕ0, j(t) is strictly positive and continuous on [a, b], along with 
some other technical regularity conditions that are listed in the Appendix. Our regularity 
conditions are similar to those used in [8]. Given assumptions A1, A2 and regularity 
conditions C1–C6, it can be shown that
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if the number of internal knots Nj = O(nν) for all j = 1, …, k, where ν satisfies 1/[2(1 + p)]< 
ν < 1/(2p) (more details on the selection of the number of internal knots are presented in 
subsection 2.1). Therefore, the B-spline-based sieve maximum likelihood estimator is 
consistent. Additionally,
This implies that the convergence rate of the estimator for the functional parameters is 
slower that the usual  rate. This estimator achieves the optimal convergence rate for 
nonparametric regression estimators which is n−p/(1+2p) when one chooses ν = 1/(1 + 2p) 
[8]. Finally,
which implies that the convergence rate of the estimator for the Euclidean parameter is . 
This also points to the efficiency of this estimator as the corresponding variance matrix 
attains the semiparametric efficiency bound I(β0). The definition of the information matrix 
I(β0) is provided in the Appendix. Since finding I(β0) involves solving an integral equation 
with no explicit solution, estimation of I(β0) by I(β̂n) is not straightforward [8, 10]. 
Consequently, one could either use the approach by Zhang et al. [8] and Li [10] for standard 
error estimation or rely on the computationally simpler nonparametric bootstrap method. 
The validity of the bootstrap for the Euclidean parameter estimates in general 
semiparametric M-estimation problems has been verified by Cheng and Huang [20]. The 
above mentioned asymptotic properties are proved in the Appendix.
2.1. Practical implementation of the method
The proposed methodology can be easily implemented using our R function ciregic. An 
example on how to use this function is provided in the Appendix. In this subsection we 
discuss the three steps that are crucial for applying our methodology in practice. The first 
and third steps are automatically implemented using our ciregicfunction.
The first step to apply the methodology is to consider the number and the placement of the 
knots for the B-splines. As it was mentioned previously, to achieve the optimal 
nonparametric convergence rate for the functional parameters, one has to select the knots 
based on the smoothness of the underlying unspecified parameters ϕ0, j(t), j = 1, …, k, as 
measured by the order p of the derivatives of these parameters that are bounded. However, 
this degree of smoothness will be unknown in practice. In this case, one can impose the 
weakest possible assumption that only the first derivative is bounded, i.e. p = 1, and proceed 
with setting ν = 1/(1 + 2p) = 1/3. Under this choice, the number of internal knots Nj has the 
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order of n1/3 and, therefore, Nj can be set equal to [n1/3] which corresponds to the largest 
integer that is smaller than or equal to n1/3. The price, however, for imposing the weakest 
possible assumption regarding the smoothness of the functional parameters is that the 
convergence rate of the estimator for the baseline cause-specific cumulative incidence 
function is n1/3. This is the slowest achievable rate for this estimator using the B-spline-
based sieve maximum likelihood approach. Based on our simulation study presented in the 
next Section, the performance of this approach is quite satisfactory even with small sample 
sizes. It has to be noted that this minimal assumption (i.e., p = 1) has been imposed in our R 
function ciregic. The placement of knots for the B-splines is an easier task since, due to 
the monotonicity constraints, these splines have better behavior compared to unconstrained 
B-splines and are less sensitive to the placement of the knots. Consequently, placing the 
knots at the quantiles of the empirical distribution of the observation times provides a 
reasonable and simple approach to knot placement.
Next, selecting the link function parameters is needed in cases where the true link functions 
are unknown a priori (as it is usually the case in practice). In this case, we propose, 
following [18], performing a grid search over a plausible combination of α1, …, αk values 
and selecting the combination with the largest maximized likelihood value. We must 
acknowledge however, that the additional uncertainty due to this type of model selection 
procedure is very difficult to estimate and this is still an open problem in the literature [19, 
18]. For this reason we assumed in all theoretical derivations that the true link functions are 
a priori known.
The final step is to obtain the parameter estimates of the model by maximizing the 
likelihood function (1) through a constrained optimization algorithm. The monotonicity 
constraints are linear inequality constraints and they can be easily incorporated in the 
optimization by using for example the logarithmic barrier method. However, incorporating 
the boundedness costraint (3) is more challenging as this is a nonlinear inequality constraint. 
For the special case with k = 2 and α1 = α2 = 1, i.e. with two competing risks and logit link 
functions for both risks, the boundedness constraint is equivalent to a linear inequality 
constraint. In this special case the optimization can be performed using a constrained 
optimization package such as the R package constrOptim, which can handle linear 
inequality constraints through the logarithmic barrier method. If there are more than 2 
competing risks or one needs to fit a wide variety of models under different combinations of 
α values, then an optimization algorithm that incorporates nonlinear inequality constraints is 
needed. In this case, the R package alabamaprovides a useful set of functions for 
optimization under both linear and nonlinear inequality constraints. Our ciregicfunction 
automatically imposes the monotonicity and boundedness constraints using the 
alabamapackage.
3. Simulation study
In order to evaluate the finite sample performance of our method, we performed a series of 
simulation experiments. We considered two causes of failure and two covariates, one binary 
(Z1) and one continuous (Z2), in the simulations. The covariates Z = (Z1, Z2)′ were 
generated from the Bernoulli distribution with probability of success 0.4 and from the 
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standard normal distribution, respectively. The cumulative incidence for causes 1 and 2 were 
considered to have a proportional odds form:
where exp [ϕ1(t)] = 0.4 [1 − exp(−0.6t)]/0.6 and exp [ϕ2(t)] = 0.75 [1 − exp(−0.5t)]/0.5 
following a Gompertz distribution [3]. The true values for the regression parameters were β1 
= (β11, β12)′ = (0.5, −0.3) and β2 = (β21, β22)′ = (−0.5, 0.3).
Based on these models, we simulated the failure times and causes of failure. The first 
observation time U1i (e.g. clinic visit) was simulated based on the exponential distribution 
with a hazard parameter equal to 3. Each one of the next observations were placed after time 
V from the previous observation, with V being generated based on the exponential 
distribution with a hazard parameter equal to 3, for a maximum period of 3 years. This 
choice led to an average time of four months between two consecutive observations. The 
number of simulated data sets was 1,000, with the sample size per data set ranging between 
200, 350 and 500. The proposed methodology was applied in each data set using cubic B-
splines, and the number of knots was set equal to the larger integer up to and including N1/3, 
with N being the total number of distinct time points Vi and Ui for the non-right-censored 
observations, plus the number of right-censored observations. The knots were placed at the 
corresponding percentiles of the distribution of the observed times (Vi,Ui). The 
nonparametric bootstrap method was used for standard error estimation of the parameter of 
interest β, based on 50 bootstrap samples. More specifically, for each simulated dataset, 50 
random samples of size n were drawn with replacement from the dataset, and then the model 
was fitted to each of these samples. The standard deviation of the corresponding 50 
regression parameter estimates was the estimated standard error of β̂n.
Simulation results regarding the baseline cumulative incidence functions are presented in 
Figure 1. Even with a sample size of 200, the average of the estimated baseline cumulative 
incidence functions were in close agreement with the corresponding true quantities. 
Regarding the regression parameter (Table 1), the method performs well, with the bias being 
very small and the empirical coverage probability staying close to the nominal 95% level in 
all cases.
4. Analysis of the HIV data
The methodology is applied to the evaluation of risk factors for the cause-specific 
cumulative incidence of being lost to care and of death while in care. Loss to care is a 
measure of patient non-retention in care, and thus is an extremely important measure for the 
success of any intervention program for the HIV/AIDS epidemic, since patients who have 
disengaged from HIV care do not receive antiretroviral treatment (ART) and thus have 
increased HIV-related mortality and morbidity, are more infectious and contribute to further 
expanding the HIV epidemic. The data came from the East Africa IeDEA (International 
Epidemiologic Databases to Evaluate AIDS) Regional Consortium, a network of HIV care 
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and treatment programs in Kenya, Uganda and Tanzania. The working definition of loss to 
care was having no clinic visits for a 3-month period. This cutoff was chosen by the 
clinicians because typically patients on ART are expected to have run out of medication if 
they have not had a clinic visit within a 3-month period. A schema of typical patient 
temporal trajectories is presented in Figure 2. Based on this figure it is clear that neither loss 
to care nor death times are exactly known due to interval censoring. In the current analysis 
we included patients with a CD4 count of at least 100 cells/μl at ART initiation. Basic 
descriptive characteristics of the study sample are presented in Table 2.
Similarly to the simulation study, we applied the proposed methodology using cubic B-
splines and with the number of knots being equal to the larger integer up to and including 
N1/3, with N being the total number of distinct time points Vi and Ui for the non-right-
censored patients plus the number of right-censored patients. The knots were placed at the 
corresponding percentiles of the distribution of the observed times (Vi,Ui). The 
nonparametric bootstrap method was used for standard error estimation of the parameter of 
interest, based on 50 bootstrap samples, as described in the simulation study Section. The 
analysis was performed using our R function ciregicthat is illustrated in the Appendix.
In order to perform the analysis we needed to select the α = (α1, α2) parameter indexing the 
link functions for loss to care and death while in care. To do so we performed a grid search 
over all possible combinations of α1 ∈ {0, 0.2, …, 10} and α2 ∈ {0, 0.2, …, 10}. The 
maximum log-likelihood value (−3144.47) was achieved at the point α = (2, 1.2). The 
maximized log-likelihood value for the popular Fine-Gray proportional subdistribution 
hazards model for both competing risks (FGFG), i.e., α = (0, 0), was −3147.05. 
Consequently, the fit of the FGFG model is clearly not optimal. In order to illustrate our 
method for the Fine-Gray model and the proporitonal odds model, which are the most 
popular choices in practice, we also fitted a model which assumes a proportional 
subdistribution hazards model for loss to care and a proportional odds model for death 
(FGPO model). In this case α was set equal to (0, 1). The maximized log-likelihood for the 
FGPO model was −3146.91. The results of the analysis based on the FGPO and the optimal 
model are presented in Table 3.
Based on Table 3, lower age at ART initiation and male gender are associated with an 
increased cumulative incidence of loss to care. Specifically, the estimate associated with age 
implies that patients older by 10 years have 21.7% lower subdistribution hazard [11] of 
being lost to care (p-value<0.001). In addition, males have 17.0% higher subdistribution 
hazard of being lost to care compared to females (p-value=0.031). Also, there is no evidence 
for an association between CD4 count at ART initiation and the cumulative incidence of loss 
to care (p-value=0.947). Older age, male gender and lower CD4 count at ART initiation are 
strongly associated with an increased odds of death while in care. It is clear that the 
interpretability of the estimated regression parameter for death while in care as odds ratios is 
very desirable, especially for non-statistically inclined investigators. We also compared the 
results from the FGPO model with those from the optimal model based on the grid search 
with α = (2, 1.2). The estimated regression coefficients are presented in Table 3 as well. The 
results from the two analyses are qualitatively similar. However, the regression coefficient 
estimates for gender and age differ substantially between the two models for the loss to care 
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outcome. As a comparison, we also performed a naïve analysis based on the midpoint 
imputation approach, under the optimal model with α = (2, 1.2). Using this approach, the 
unknown failure times are replaced by the midpoint between the two observation times that 
surround the true failure time, and then the data are analyzed as usual right-censored data. 
The estimate for the effect of CD4 on loss to care, based on the naïve analysis, was 10.9 
times larger (0.011 versus 0.001) compared to the estimate from the proposed approach, 
although this effect was still not statistically significant. Additionally, the estimate of the 
effect of age on death was attenuated by 8.3% based on the naïve analysis compared to the 
estimate from the proposed method. However, this effect was still statistically significant. 
The difference between the rest estimates from the two approaches was less than 3.4%.
It is straightforward to derive predicted cause-specific cumulative incidence functions for 
specific patient subgroups. Figure 3 presents results of these quantities, based on the 
estimates from the optimal model, for a female patient with CD4 count at ART initiation of 
120 cells/μl, by age at ART initiation. Such predictions are useful for evaluating program 
effectiveness and can also be used as inputs to mathematical models of cost-effectiveness 
analyses to identify the best strategy to optimize care in our setting. The comparison 
between the predictions from the optimal model and the FGPO model are presented in the 
bottom row of Figure 3. For the loss to care outcome, the predicted cumulative incidences 
for a 40-year old male patient with a CD4 count at ART initiation of 120 cells/μl from the 
two models differ substantially. More specifically, the difference between the two age groups 
is smaller after the first year based on the optimal model compared to the FGPO model. This 
provides some evidence for the violation of the proportional subdistribution hazards 
assumption of the Fine-Gray model. However, when considering the death outcome, the 
predicted cumulative incidences from the two models are quite close, and this is because the 
difference between the link function parameters in the two models is somewhat small (i.e., 
α2 = 1.2 for the optimal model and α2 = 1 for the FGPO model).
5. Discussion
In this paper we extended the work by Li [10] on semiparametric analysis of the 
proportional subdistribution hazards or the Fine-Gray model [11] for cumulative incidence 
incidence estimation with interval-censored competing risk data, to the class of the 
semiparametric generalized odds rate transformation models. This general class includes the 
proportional odds model [3, 6] and the proportional subdistribution hazards model as special 
cases. This extension is very important for medical and epidemiological applications when 
the proportional subdistribution hazards model does not provide good fit to the data, as was 
the case with our HIV data analysis. Unlike [10], we also explicitly incorporate the 
boundedness of the cause-specific cumulative incidence function constraint into the 
optimization, and we also provide and illustrate an R function called ciregic, that easily 
implements the proposed method.
We have showed that the B-spline sieve maximum likelihood estimator for the regression 
(Euclidean) parameter, under the class of the generalized odd rate transformation models is 
consistent, semiparametrically efficient and asymptotically normal. It was also shown that 
the estimator for the functional parameter (baseline cumulative incidence functions) is 
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consistent in an L2-metric and converges at the optimal rate for nonparametric regression 
which is nevertheless slower than the usual parametric  rate. This methodology is also 
applicable to the case of current status data [21, 22] since these data are special cases of 
interval-censored data [8]. It is straightforward to show that our results also hold for the 
more general class of semiparametric transformation models.
Throughout this paper we assumed that the true link functions are known as in [16, 17, 12, 
18]. A practical issue regarding the application of the proposed method in practice is when 
this assumption is not true. To this end, and simiarly to Mao and Wang [18], we proposed 
performing a grid search over a plausible set of combinations of (α1, …, αk) and choosing 
the combination with the largest maximized likelihood value. This approach for selecting the 
proper link function parameter values was illustrated in an analysis of data from a large 
network of HIV care and treatment programs in sub-Saharan Africa. The issue of the 
additional variability due to this type of model selection is still an open problem and requires 
further investigation.
Our approach simultaneously estimates the models for all causes of failure in contrast to 
many semiparametric methods for right-censored competing risk data. Analysis of all the 
competing causes of failure is essential for a more complete understanding of the underlying 
competing risks process. However, this comes at the cost of specifying a model for every 
cause of failure and can increase the risk of model misspecification, even though our method 
is very flexible in terms of the baseline cumulative incidence functions and the link 
functions.
In general, fully parametric methods can be straightforwardly extended to the case of 
interval censoring, and have the advantage of being efficient. However, the validity of these 
methods relies on strong assumptions for each cause of failure and this limits their 
generality. One solution is to adopt more flexible 3-parameter distributions as in [5] and [6]. 
However, while these distributions are clearly less flexible than the B-spline approximations 
used in this paper, they may also be plagued by non-convergence issues such as in univariate 
survival analysis [7]. By contrast, when using our proposed methods, we did not face non-
convergence problems in either in the simulations or the analysis of the HIV data. A 
disadvantage of our method, compared to parametric approaches, is that it does not provide 
estimates of the long term proportions for each cause of failure. Even though this is possible 
with parametric approaches as well [23, 3, 6, 2], care is needed when making extrapolations 
beyond the observable time interval as mentioned by Jeong and Fine [3].
In this paper, we did not consider the asymptotic distribution of the estimated baseline and 
covariate-specific cumulative incidence functions as the slower rate of convergence of this 
estimator make this task considerably difficult. However, evaluating the uncertainty of 
model-based predictions of the cumulative incidence is very useful from a clinical and 
implementation science perspective. Therefore, it would be useful to study the asymptotic 
properties of the estimated baseline and covariate-specific cumulative incidence functions 
and propose a method for the calculation of confidence intervals and simultaneous 
confidence bands. Additionally, the issue of quantifying the uncertainty due to the link 
function selection is another interesting and challenging issue for future research.
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Appendix
The R function ciregic
The R function ciregic, which can be found in the online material of this manuscript, 
implements the methods proposed in this work. This function depends on the package 
alabama that performs optimization with both linear and nonlinear inequality constraints. 
Therefore, prior installation of this package is required in order to use the ciregic 
function. The first step is to install/define the ciregic function, which can be done by 
either running the script ciregic.R provided in the online material of this manuscript, or 
by storing it in the working folder and then using the command
source(“ciregic.R”)
In this illustration we use the HIV dataset that was analyzed in this manuscript. We load and 
list the first records of these data using the commands
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The variables v and u are the lower and upper observation times V and U, respectively. 
These times correspond to years since ART initiation. The variable c is the cause of failure, 
where the loss to care event is coded as c=1, the death event as c=2, and the right-censoring 
as c=0. Note that the u values for the right-censored observations (i.e., c=0) are not included 
in any calculation. This is because in theory, U = ∞ for right-censored observations. 
Therefore, these times have been previously replaced with the lower observation times v 
plus 1 day as
data$u<-(data$v+1/365.25)*(data$c==0)+data$u*(data$c>0)
Performing the analysis that was presented in the HIV data example section based on the 
Fine-Gray model for loss to care and the proportional odds model for death, which 
correspond to α = (0, 1), requires the commands
In order to achieve reproducibility of the standard error estimates, as they are based on the 
bootstrap, we need to manually set a random seed as presented above. The first argument in 
the Surv2 function is the lower observation time V, the second is the upper observation time 
U, and the third is the cause of failure variable. The last variable should include 0 for right-
censored observations, and 1 and 2 for causes of failure 1 and 2, respectively. Currently, we 
allow for only two competing risks, but we plan to extend this to three or more in the near 
future. The output presented above corresponds to the first column of Table 3. Note that in 
that table, the effects of age and CD4 count have been multiplied by 10 and 100, 
respectively, for interpretation purposes. The object fit.01 is a list that contains an output 
of the analysis in the first component, the regression parameter estimates and the 
corresponding variance-covariance matrix in the second and third components respectively, 
and the value of the maximized log-likelihood in the eighth component. Indication of 
successful convergence of the optimization algorithm is stored in the ninth component of 
fit.01. The components 4 to 7, include the estimated baseline cumulative incidence 
functions and some other elements that are useful for estimating the covariate- specific 
cumulative incidence function using our pred.cif function. The estimation with 50 
bootstrap replications and a dataset of 3,053 observations required 11.65 minutes. We plan 
to optimize the computational efficiency of our function by utilizing multiple cores, and to 
upload it in CRAN as a package. Estimation of the optimal model for this analysis with α = 
(2, 1.2) can be performed using the command
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set.seed(20835)
fit.opt<-ciregic(formula=Surv2(v, u, c)∼ male + age_art + cd4_art,
                         data=data, alpha=c(2,1.2), nboot=50)
Incorporation of an interaction effect between gender and age at ART initiation could be 
simply incoprorated as
fit.opt<-ciregic(formula=Surv2(v, u, c)∼ male*age_art + cd4_art,
                         data=data, alpha=c(2,1.2), nboot=50)
Estimation of the covariate-specific cumulative incidence function can be easily performed 
using the pred.cif function. The first argument in this function is the object containing the 
results from the model fit generated by the ciregic function, and the second the desired 
covariate pattern as a vector. For example, in order to estimate the cumulative incidence 
function of loss to care and death for a 20-year old female with a CD4 count of 120 cells/μl 
at ART initiation, we need the command
f20.01<-pred.cif(fit.01, covp=c(0,20,120))
head(f20.01)
##            t         cif1        cif2
## 1 0.00000000 4.996004e-15 0.001595043
## 2 0.05265523 7.882583e-15 0.007162271
## 3 0.10531046 5.606626e-14 0.012532213
## 4 0.15796569 1.477572e-07 0.015031502
## 5 0.21062092 4.201278e-02 0.017972113
## 6 0.26327615 1.896563e-01 0.019366670
The option covp should include the desired covariate values, in the same order as the listing 
order of the corresponding covariates in the right side of the formula argument in ciregic 
function. As in any other prediction problem, these covariate values should not be outside 
the observable range of covariate values in order to avoid extrapolation. The function 
pred.cif returns a data frame that includes times and the estimated cumulative incidence 
functions for both failure causes and for the desired covariate pattern. Plotting the object 
f20.01 in the example above (e.g., with the plot function) will provide the estimated 
cumulative incidences that are depicted in the second row of Figure 3 as solid grey lines.
Proof of consistency
Empirical process theory techniques will be applied to derive the consistency of the B-spline 
sieve maximum likelihood estimator. As usual P f = ∫  f (x)d P(x) and 
, which is the empirical process indexed by the function f evaluated at 
, the sample point of individual i, with 
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denoting the sample space. Also, let C denote a general constant which may differ in 
different settings. The following regularity conditions are assumed
C1 E(Z Z′) is non-singular and Z is bounded, i.e. there exists a z0 > 0 such that P(||
Z|| ≤ z0) = 1.
C2 βj ∈ ℬj, where ℬj is a compact subset of ℝd for every j = 1, …, k.
C3 There exists an η > 0 such that P(U − V ≥ η) = 1 and the union of the supports 
of V and U are contained in [a, b], where 0 < a < b < ∞ and 
.
C4 ϕ0, j ∈ Φ, where Φ is a class of functions with bounded p-th derivative in [a, b] 
for p ≥ 1 and the first derivative of ϕ0, j is strictly positive and continuous on [a, 
b]. This holds for all j = 1, …, k.
C5 The conditional density of (V,U) given Z has bounded partial derivatives with 
respect to (v, u) and the bounds of these derivatives do not depend on (v, u, z).
C6 For some κ ∈ (0, 1), a′Var(Z|V)a ≥ κa′E(ZZ′|V)a a.s. and a′Var(Z|U)a ≥ κ a
′E(ZZ′|U)a a.s. for all α ∈ ℝd.
Let ℱ1 = {l(θ; X): θ ∈ Θn} denote the class of log-likelihood functions indexed by the 
parameter space . The Euclidean parameters are βj ∈ ℬj and the 
functional parameters are ϕj ∈ℳn, j, for j = 1, …, k. The functional parameter space ℳn, j ≡ 
ℳn(γj, Nn, j, pj) is the space of monotone B-spline functions defined on the observation time 
interval [a, b]. Convergence will be proved in the L2-metric
for θ1 = (β(1)′, ϕ(1)′)′ and θ2 = (β(2)′, ϕ(2)′)′, where
Let (θ) = Pl(θ; X) and n(θ) = ℙnl(θ; X), which leads to n(θ) − (θ) = (ℙn − P)l(θ; X) 
for each θ ∈ Θn. In order to prove that  we need to verify the following 
conditions:
1.
2. supθ: d(θ, θ0)≥ε (θ) < (θ0)
3. The sequence of estimators θ̂n satisfy n(θ̂n) ≥ n(θ0) − op(1)
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It has been shown that there exists a set of brackets {[ ]: i = 1, …, (1/ε)Cqn, j}, where 
C is a constant and qn, j = Nn, j + p j + 1, with Nn, j and p j being the number of internal knots 
and the degree of the B-spline for the j-th cause of failure, such that  and 
 for any t ∈ [a, b] and i = 1, …, (1/ε)Cqn, j [9]. By condition C2, ℬj ⊂ 
ℝd is compact and thus it can be covered by C(1/ε)d ε-balls, i.e. for any β ∈ ℬj there exists 
an s = 1, …,C(1/ε)d such that β ∈ B(βs, j) ≡ {b ∈ ℬj: |b − βs, j | ≤ ε}. By condition C1 it 
follows that for any β ∈ ℬj and any z, . Let 
. Then, for any j = 1, …, k we can construct a set of 
brackets{[ ]: i = 1, …, (1/ε) Cqn, j; s = 1, …,C(1/ε)d }, with 
 and , such that 
 and  for any t ∈ [a, b] and z ∈ Z. So, 
for any cause of failure j = 1, …, k it is straightforward to construct a set of brackets 
{[ ]: i = 1, …, (1/ε)Cqn, j; s = 1, …,C(1/ε)d } with:
and
such that there exists an s = 1, …,C(1/ε)d and an i = 1, …, (1/ε)Cqn, j such that 
 for any t ∈ [a, b] and z ∈ Z. Using Taylor approximation 
along with conditions C1, C2 the constraint  and the fact that αj < ∞ for 
all j = 1, …, k, we can show that  and the bracketing number with the 
L1(ℙn)-norm is bounded by C(1/ε)d+Cqn, j, for any j = 1, …, k, s = 1, …,C(1/ε)d and i = 1, 
…, (1/ε)Cqn, j . Consequently, we can construct a set of brackets 
{[ ]: ij = 1, …, (1/ε)Cqn, j, sj = 1, …, Cj (1/ε)ν}, where k is the 
fixed and finite number of competing risks, with
where , δj = I{V<X≤U,δ=j},  and
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such that for any j = 1, …, k there exists an i j = 1, …, (1/ε)Cqn, j, sj = 1, …,Cj (1/ε)ν so that 
 for any sample point X ∈ . Using Taylor 
approximation and regularity conditions C1–C3 it can be shown that 
, for any j, i j and s j . Additionally, the bracketing 
number N[](Cε,ℱ1, L1(ℙn)) is bounded by . Since qn, j = nrj + m, with 
r j ∈ (0, 1), it follows that log N[](Cε,ℱ1, L1(ℙn)) = o(n), for any ε > 0. Also, due to 
condition C3 there exists an envelope F for the class of likelihood functions ℱ1 such that 
P*F < ∞ and log N(ε,ℱ1, L1(ℙn)) ≤ log N[](2ε,ℱ1, L1(ℙn)) [8]. Consequently, ℱ1 is 
Glivenko-Cantelli by Theorem 2.4.3 of [24]. Consequently
Next we are going to show that condition 2., i.e. supθ: d(θ, θ0)≥ε (θ) < (θ0), holds. By 
definition we have:
where, as in [8], m(x) = x log x − x + 1 ≥ (1/4)(x − 1)2 for x ∈ [0, 5], and thus for any θ in a 
sufficiently small neighbourhood of θ0 we have
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where the last equality follows from a Taylor expansion around the value of the linear 
predictor ηj (X). Using the same arguments as in [25], pp. 2126–2127, along with regularity 
conditions C1–C6 it follows that
Consequently
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and we have proven condition 2.
Finally, we prove condition 3, i.e. that the sequence of estimators θ̂n satisfy n(θ̂n) ≥ n(θ0) 
− op(1). It has been shown that for ϕ0, j ∈ Φ there exists a θ0,n, j ∈ℳn, j of order m ≥ p + 2 
such that  [26]. This also implies that 
 [8]. Of course the previous result holds for any j = 1, …, 
k. Letting θ0,n = (β0, ϕ0,n) it follows that
(4)
Similar to [8], we consider the class of functions ℱ2 = {l(β0, ϕ; X) − l(β0, ϕ0; X): ϕj ∈ℳj,n, ||
ϕj − ϕ0, j||Φ ≤ Cn−pν for any j = 1, …, k} and construct a set of ε-brackets with L2(P))-norm 
bounded by . Consequently, the corresponding bracketing integral
because the integral above is bounded by 1 [27] and thus by theorem 19.5 of [28] ℱ2 is P-
Donsker. Using the fact that ||ϕj − ϕ0, j||Φ ≤ Cn−pν in ℱ2 and the boundedness of l(·; X), 
along with the dominated convergence theorem we can show that limn→∞ P[l(β0, ϕ; X) − 
l(β0, ϕ0; X)]2 = 0. Using the fact that for a P-Donsker class of functions there exists a 
semimetric ρp that makes that class totally bounded and that  is 
asymptotically equicontinuous by corollary 2.3.12 of [24] it follows that:
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Next, for the remaining term in (4) we can again use the boundedness of the loglikelihood 
function for any sample point X ∈  and that ||ϕ0,n, j − ϕ0, j||Φ = O(n−pν), along with the 
dominated convergence theorem it follows that
as n → ∞. Thus
and this proves the final consistency condition. Consequently
Proof of rate of convergence
Derivation of the rate of convergence will be based on theorem 3.2.5 of [24]. We showed in 
the proof of consistency that
and that
where I1,n = (ℙn − P)[l(β0, ϕ0,n; X) − l(β0, ϕ0; X)] and I2,n = P[l(β0, ϕ0,n; X) − l(β0, ϕ0; X)]. 
Applying a Taylor expansion leads to
for any 0 < ε < 1/2 − pν. The uniform boundedness of l̇2(β0, ϕ̃; X) due to the conditions 
C1–C4 and the fact that ||ϕ0,n − ϕ0||∞ = O(n−pν) [26] lead to
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Since ℱ2 is P-Donsker and by corollary 2.3.12 of [24] we have that
Consequently,
Since the function m(x) = x log x − x + 1 is bounded by ≤ (x − 1)2 in a neighbourhood of x = 
1, it follows that
and thus
Consequently,
Defining the class of functions ℱ3(η) = {l(θ; X) − l(θ0; X): ϕj ∈ℳn, j and d(θ, θ0) ≤ η} and 
using similar arguments as in the proofs of consistency, we have that
and thus
Now, using the uniform boundedness of l(θ; X) as a result of conditions C1 and C3, and 
theorem 3.4.1 of [24], the function ϕn(η) of theorem 3.2.5 [24] is
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Also, we have that
Consequently, if pν ≤ (1 − ν)/2 then n2pνϕn(1/npν) ≤ n1/2. Based on this and in accordance 
with [8] we conclude that if we choose rn = min(pν, (1 − ν)/2), then  and 
. Therefore
Proof of asymptotic normality
In order to prove the asymptotic normality of the estimator for Eucidean parameter β̂n we 
need to verify that the information matrix I (β0) is nonsingular and also the conditions of 
theorem 3 of [8]. These conditions are
B1 ℙnl̇1(βn̂, β̂n; X) = op(n−1/2) and ℙnl̇2(β̂n, ϕ̂n; X)(ξ 0) = op(n−1/2)
B2 (ℙn − P)[l*(β̂n, ϕ̂n; X) − l*(β0, ϕ0; X)] = op(n−1/2)
B3 P[l*(β̂n, ϕ̂n; X) − l*(β0, ϕ0; X)] = −I (β0)(β̂n − β0) + op(||β̂n − β0||) + op(n−1/2)
Information for β
At first we will show that the information matrix I (β0) is nonsingular. Generically, the 
likelihood for an individual observation is
where
We will carry out the calculations for the proportional subdistribution hazards model (i.e. αj 
= 0). The proof for any other combination of link functions with 0 ≤ αj < ∞, follows from 
similar arguments and calculations. The likelihood for an individual observation, under αj = 
0 for all j = 1, …, k is:
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where Λj = exp(ϕj) is the cumulative subdistribution hazard for the j-th cause of failure [11]. 
The score function for βj (j = 1, …, k) is
Let
The score operator for Λj (j = 1, …, k) is
Let
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Then,
and
Next, for any j = 1, …, k, we need to find
and
The random variables here are ( , δj, δ,U, V). Assume U, V the same for all j = 1, …, k and 
that condition C3 holds. Since the event  is equivalent to Tj < V and Tj ≤ Tl for any l = 
1, …, k we have that
where g(v, u|z) if the density of (V,U) conditinal on Z = z. Similarly, since the event δj = 1 is 
equivalent to Tj ∈ (V,U) and Tj ≤ Tl for any l = 1, …, k we have that
Bakoyannis et al. Page 26
Stat Med. Author manuscript; available in PMC 2018 October 15.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Finally, we have that
where t = min(tj: j = 1, …, k). We also have that,
Now
Similarly,
Now,
Let,
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Then,
Let,
Then,
Denote,
and
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We need to find h1, …, hk s.t.
or equivalently
We have that
Let,
Then,
for tj ≤ tl, for any l = 1, …, k. Similarly let
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Then,
for tj ≤ tl, for any l = 1, …, k. Therefore
where
and
Now, as in [29] by lemma 6.1 [29], the fact that K(tj, x) is a bounded kernel and Fredholm 
integral equations results, there exists a 0(tj, x) such that
Thus, similarly to [29] (pp. 159),  is differentiable with a bounded derivative.
Verification of conditions B1–B3
For condition B1 we need to show that
since ℙnl̇1(β̂n, ϕ̂n; X) = 0. ξ0 has a bounded derivative and it is also a function with bounded 
variation [8]. Define Sn(Dn, Kn,m) to be the space of polynomial spline functions s of order 
m ≥ 1, with the restriction of s to any of the Kn subinterval being a polynomial of order m ≤ 
Kn and for m ≥ 2 and 0 ≤ m′ ≤ m − 2, s is m′ times continuously differentiable on [a, b]. 
Then it can be shown using the argument in [30] pp. 435–436 that there exists a ξ0,n ∈ 
Sn(Dn, Kn, m) such that
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and ℙnl̇2(θ̂n; X)(ξ0,n) = 0. Consequently,
where
and
Let ℱ4 = {l̇2(θ; x)(ξ0 − ξ): θ ∈ℳn, ξ ∈ Sn(Dn, Kn,m) and ||ξ0 − ξ||Φ ≤ n−ν }. Similarly, it 
can be shown that
and this leads to ℱ4 being Donsker. Also, for any r ∈ ℱ4, Pr2 → 0 as n → ∞ and thus I3,n 
= op(n−1/2) by corollary 2.3.12 of [24]. Finally, based on the Cauchy-Schwartz inequality 
and regularity conditions C1–C4 we have that
and thus we proved condition B1.
For condition B2 define the class of functions
Using similar arguments as before, we can show that ℱ5(η) is P-Donsker and that for any r 
∈ ℱ5, Pr2 → 0 as η → ∞ and therefore condition B2 holds. Finally, it is a straightforward 
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task to show condition B3 based on Taylor expansion and the convergence rate of the 
estimator. Thus
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Figure 1. 
True (grey lines) and average estimated (black dashed lines) baseline cumulative incidence 
functions based on 1,000 simulation replications according to cause of failure and sample 
size n.
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Figure 2. 
Example of four patients in a typical HIV care and treatment program.
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Figure 3. 
Estimated cumulative incidence of loss to care (top left panel) and of death (top right panel) 
for a female patient with a CD4 count of 120 cells/μl at ART initiation, according to age at 
ART initiation (solid lines = 20 years; dashed lines = 30 years; dotted lines = 40 years; 
dashed-dotted lines = 50 years) based on the optimal model according to the grid search, 
with α = (2, 1.2), and estimated cumulative incidence of loss to care (bottom left panel) and 
of death (bottom right panel) for a male patient with a CD4 count of 120 cells/μl at ART 
initiation, according to age (solid lines = 20 years; dashed-dotted lines = 50 years), based on 
the optimal model (black lines) and the Fine-Gray – proportional odds model (gray lines) 
with α = (0, 1).
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Table 2
Descriptive characteristics of the study sample.
In HIV care (n=2,232)
n (%) LTC
1
 (n=690)
n (%)
Death2 (n=131)
n (%)
Gender
 Male 681 (30.5) 207 (30.0) 62 (47.3)
 Female 1,551 (69.5) 483 (70.0) 69 (52.7)
HIV status disclosed
 No 763 (34.2) 279 (40.4) 57 (43.5)
 Yes 1,469 (65.8) 411 (59.6) 74 (56.5)
Median (IQR) Median (IQR) 40.9 (35.0, 50.8)
Age3 (years) 37.1 (30.4, 44.9) 35.2 (28.6, 41.7)
CD43 (cells/μl) 199 (152, 276) 188 (140, 262) 163 (131, 213)
1
Loss to care
2While in HIV care
3At ART initiation
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Table 3
Comparison between the results from the Fine-Gray – proportional odds model (FGPO) with α = (0, 1) and 
the optimal based on the grid search model with α = (2, 1.2)
Outcome Covariate
α = (0, 1)
mRR1/β̂(p-value)
α = (2, 1.2)
β̂ (p-value)
A. Loss to care Age at ART initiation
 per 10 years 0.7832/−0.244 (<0.001) −0.348 (<0.001)
Gender
 Male vs Female 1.1702/0.157 (0.031) 0.273 (0.005)
CD4 at ART initiation
 per 100 cells/μl 1.0022/0.002 (0.947) 0.001 (0.976)
B. Death Age at ART initiation
 per 10 years 1.3603/0.308 (<0.001) 0.329 (<0.001)
Gender
 Male vs Female 1.7583/0.564 (0.008) 0.567 (0.008)
CD4 at ART initiation
 per 100 cells/μl 0.6993/−0.358 (0.003) −0.346 (0.006)
1
Measure of relative risk
2Subdistribution hazard ratio
3Odds ratio
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